Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment of Functional Ovarian Cyst
NCT05244811Phase 3Unknown
- Sponsor
- Sohag University
- Start
- Feb 2022
- Primary completion
- Jan 2023
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of estradiol valerate + norgestrel and norethindrone acetate transdermal delivery system in functional ovarian cyst (3 arms), sponsored by Sohag University. Primary endpoint: treatment of functional ovarian cysts at 1 year. Status: unknown.
02
Drugs
estradiol valerate + norgestrelnorethindrone acetate transdermal delivery system
03
Conditions
functional ovarian cyst
Beyond the preview
Go deeper on NCT05244811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05244811.